Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0001
0.0000
(0.00%)
At close: February 21 at 3:00:00 PM EST
Breakdown
TTM
Operating Expense
398.9370
Operating Income
-398.9370
Net Non Operating Interest Income Expense
-273.7760
Other Income Expense
-243.4790
Pretax Income
-916.1920
Net Income Common Stockholders
-916.1920
Diluted NI Available to Com Stockholders
-916.1920
Basic EPS
-0.01
Diluted EPS
-0.01
Basic Average Shares
57,439.4610
Diluted Average Shares
57,439.4610
Total Operating Income as Reported
-398.9370
Total Expenses
398.9370
Net Income from Continuing & Discontinued Operation
-916.1920
Normalized Income
-672.7130
Interest Expense
273.7760
Net Interest Income
-273.7760
EBIT
-642.4160
EBITDA
-641.7100
Reconciled Depreciation
0.7060
Net Income from Continuing Operation Net Minority Interest
-916.1920
Total Unusual Items Excluding Goodwill
-243.4790
Total Unusual Items
-243.4790
Normalized EBITDA
-398.2310
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
600161.SS TIANTAN BIO
20.05
-0.35%
96X.F FluoGuide A/S
3.7550
-6.24%
RGO.DU Regeneron Pharmaceuticals Inc
657.40
+1.20%
PH4.F CStone Pharmaceuticals
0.3720
+4.49%
HQ1.MU Oruka Therapeutics Inc. R
10.60
+0.95%
GYX.F Futura Medical plc
0.1770
+14.94%
IMMB Immunotech Laboratories, Inc.
0.0001
0.00%
10VA.F Immunic, Inc.
1.2360
+14.98%
2563.HK Beijing Biostar Pharms Co Ltd
17.680
-1.78%
49BA.SG BeiGene Ltd
248.00
+9.73%